Cullinan Therapeutics, Inc.CGEMNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank71
3Y CAGR+48.3%
5Y CAGR+90.1%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+48.3%/yr
vs +102.4%/yr prior
5Y CAGR
+90.1%/yr
Recent deceleration
Acceleration
-54.1pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
24.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $21.77M | -26.1% |
| 2024 | $29.46M | +34.7% |
| 2023 | $21.87M | +227.9% |
| 2022 | $6.67M | +1321.7% |
| 2021 | $469000.00 | -46.5% |
| 2020 | $877000.00 | +42.4% |
| 2019 | $616000.00 | +55.2% |
| 2018 | $397000.00 | - |